Position in ANIP
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,544,739
+$427,067 QoQ
Shares Held
30,741
+11.6% QoQ
Ownership
0.134%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#101
of 303 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 67%
Shared 0%
None 33%
Common Shares in ANIP Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MARTINGALE ASSET MANAGEMENT L P holds $52,615,067 across 17 Drug Manufacturers - Specialty & Generic names. ANIP ranks #8 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
69,799 | $11,763,923 | |
| 2 | ALKS |
Alkermes plc.
|
170,004 | $8,908,209 | |
| 3 | AMRX |
Amneal Pharmaceuticals, Inc.
|
283,033 | $4,899,301 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
7,622 | $4,129,828 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
85,564 | $3,510,690 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
74,348 | $3,457,925 | |
| 7 | PCRX |
Pacira BioSciences, Inc.
|
112,025 | $2,842,074 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
This page
|
30,741 | $2,544,739 |
All Filings in ANIP
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,544,739 | 30,741 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,117,672 | 27,538 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,854,142 | 23,488 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,172,202 | 23,714 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,573,438 | 24,114 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,581,024 | 23,615 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,447,064 | 26,177 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,072,587 | 34,740 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,338,617 | 21,021 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,274,135 | 18,431 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $938,482 | 17,020 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $988,181 | 17,020 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $916,240 | 17,021 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $644,298 | 16,221 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $652,570 | 16,221 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $511,861 | 15,926 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $380,547 | 12,826 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $289,785 | 10,309 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $438,128 | 9,508 | Shares | Sole | 2022-02-11 | |
| 2020-09-30 | $671,651 | 23,809 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,633,461 | 50,509 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $2,057,899 | 50,513 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||